MoneyWorks4Me

Dr Reddy's Laboratories reply to clarification sought by exchange

05 Apr 2022 Evaluate

Dr Reddy's Laboratories has informed that the Exchange had sought clarification with respect to news article appearing on https://economictimes.indiatimes.com dated March 31, 2022 titled ‘Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance’. Dr Reddys Laboratory’s response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1303.00
Cipla 1353.00
Lupin 1950.00
Zydus Lifesciences 1158.10
View more..